Pharmacokinetics of cefquinome after single and repeated subcutaneous administrations in sheep.
暂无分享,去创建一个
[1] Y. Lu,et al. In vivo activity of cefquinome against Riemerella anatipestifer using the pericarditis model in the duck. , 2016, Journal of veterinary pharmacology and therapeutics.
[2] F. Mahmoud,et al. Pharmacokinetics of cefquinome following multiple doses intramuscular administration in goats using HPLC , 2016 .
[3] Yahong Liu,et al. In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes , 2015, Antimicrobial Agents and Chemotherapy.
[4] N. Zhang,et al. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model , 2015, BMC Veterinary Research.
[5] Shuyu Xie,et al. Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle , 2015, Front. Microbiol..
[6] K. A. Sadariya,et al. Blood parameters on concurrent administration of cefquinome and tolfenamic acid in sheep , 2015 .
[7] N. Zhang,et al. In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model , 2014, BMC Veterinary Research.
[8] Z. Zeng,et al. In Vivo Activity of Cefquinome against Escherichia coli in the Thighs of Neutropenic Mice , 2014, Antimicrobial Agents and Chemotherapy.
[9] M. Aboubakr,et al. Comparative Pharmacokinetics of Cefquinome (Cobactan 2.5%) following Repeated Intramuscular Administrations in Sheep and Goats , 2014, Journal of veterinary medicine.
[10] Z. Zeng,et al. Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Staphylococcus aureus Infection , 2014, Antimicrobial Agents and Chemotherapy.
[11] I. Wijnberg,et al. Comparing the pharmacokinetics of a fourth generation cephalosporin in three different age groups of New Forest ponies. , 2012, Equine veterinary journal. Supplement.
[12] K. Eltom,et al. Prevalence of Staphylococcus aureus subsp. anaerobius in sub-clinical abscess cases of sheep. , 2012 .
[13] M. A. Tohamy. Age-related intramuscular pharmacokinetics of cefquinome in sheep , 2011 .
[14] F. Altan,et al. Development and Validation of a High-Performance Liquid Chromatography Method for Determination of Cefquinome Concentrations in Sheep Plasma and Its Application to Pharmacokinetic Studies , 2010, Antimicrobial Agents and Chemotherapy.
[15] D. Paterson,et al. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. , 2010, International journal of antimicrobial agents.
[16] A. Widmer,et al. Comparison of the clinical efficacy of cefquinome with the combination of penicillin G and gentamicin in equine patients , 2009 .
[17] D. Su,et al. Pharmacokinetics and bioavailability of cefquinome in healthy piglets. , 2008, Journal of veterinary pharmacology and therapeutics.
[18] S. Bell. Respiratory disease in sheep , 2008, In Practice.
[19] Jiang Chun-mao. Pharmacokinetics of cefquinome sulfate suspension in pigs , 2007 .
[20] M. Kietzmann,et al. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder. , 2006, Veterinary journal.
[21] C. Wilhelm,et al. Antibacterial activity of cefquinome against equine bacterial pathogens. , 2006, Veterinary microbiology.
[22] D. Maes,et al. Determination of cefquinome concentrations in bronchoalveolar lavage fluid , 2006 .
[23] P. Toutain,et al. Bioavailability and its assessment. , 2004, Journal of veterinary pharmacology and therapeutics.
[24] P. Toutain,et al. Volumes of distribution. , 2004, Journal of veterinary pharmacology and therapeutics.
[25] K. Waldmann,et al. Vorschläge der Arbeitsgruppe "Antibiotikaresistenz" für die Belegung von Mikrotiterplatten zur Empfindlichkeitsprüfung von Bakterien gegenüber antimikrobiellen Wirkstoffen in der Routinediagnostik: Mastitis- und Großtierlayouts , 2004 .
[26] A. Böttner,et al. Comparative field efficacy study between cefquinome and gentamicin in neonatal calves with clinical signs of septicaemia , 2004 .
[27] P. Toutain,et al. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. , 2002, Research in veterinary science.
[28] E. Zschiesche,et al. A field study of cefquinome for the treatment of pigs with respiratory disease , 2002 .
[29] J. Turnidge. The Pharmacodynamics of β-Lactams , 1998 .
[30] N. Shpigel,et al. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. , 1997, Journal of dairy science.
[31] R. Jones,et al. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals. , 1994, Diagnostic microbiology and infectious disease.
[32] H. Neu,et al. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics. , 1992, Diagnostic microbiology and infectious disease.
[33] G. Seibert,et al. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin , 1991, Antimicrobial Agents and Chemotherapy.
[34] G. Fischer,et al. Recent Developments in the Field of Cephem Antibiotics , 1989 .
[35] W. Colburn. Estimating the accumulation of drugs. , 1983, Journal of pharmaceutical sciences.
[36] J. Rossum. Pharmacokinetics of accumulation , 1968 .